ALLIANCEBERNSTEIN L.P. - AKCEA THERAPEUTICS INC ownership

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of AKCEA THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$780,000
+9.7%
43,000
-17.1%
0.00%
Q2 2020$711,000
+32.2%
51,900
+38.0%
0.00%
Q1 2020$538,000
-7.4%
37,600
+9.6%
0.00%
Q4 2019$581,000
+14.1%
34,300
+3.6%
0.00%
Q3 2019$509,000
-34.4%
33,1000.0%0.00%
Q2 2019$776,000
+3.7%
33,100
+25.4%
0.00%
Q1 2019$748,000
-14.7%
26,400
-9.3%
0.00%
-100.0%
Q4 2018$877,000
-8.9%
29,100
+5.8%
0.00%0.0%
Q3 2018$963,000
+11.6%
27,500
-24.5%
0.00%0.0%
Q2 2018$863,000
+31.6%
36,400
+42.2%
0.00%
Q1 2018$656,000
+100.0%
25,600
+35.4%
0.00%
Q4 2017$328,00018,9000.00%
Other shareholders
AKCEA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Bellevue Group AG 3,162,643$53,575,0000.85%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 31,723$536,0000.19%
Amia Capital LLP 28,217$478,0000.14%
Motley Fool Asset Management LLC 60,489$1,025,0000.11%
Virtus ETF Advisers LLC 33,059$560,0000.09%
ALTRINSIC GLOBAL ADVISORS LLC 70,286$1,191,0000.05%
A.R.T. Advisors, LLC 53,560$907,0000.04%
TUDOR INVESTMENT CORP ET AL 46,433$787,0000.04%
Caption Management, LLC 54,000$915,0000.03%
Caption Management, LLC 54,000$915,0000.03%
View complete list of AKCEA THERAPEUTICS INC shareholders